{
  "trial_id": "NCT00446030",
  "trial_group": "cancer",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, histological type of breast cancer, type of surgical treatment, lymph node status, tumor size, estrogen receptor status, progesterone receptor status, HER2/neu status, ECOG performance status, left ventricular ejection fraction (LVEF), absolute neutrophil count (ANC), platelet count, hemoglobin level, bilirubin level, AST level, prior radiation therapy, prior systemic anticancer therapy, presence of motor or sensory neurotoxicity, cardiac history, presence of other serious illnesses or medical conditions, urine protein:creatinine ratio, history of other neoplasms, concurrent hormonal therapy, concurrent corticosteroid treatment, concurrent experimental drug treatment, hypersensitivity to study drugs, surgical history, mental condition or psychiatric disorder, compliance likelihood.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Eastern Cooperative Oncology Group (ECOG) performance status score",
          "ECOG performance status"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Race/Ethnicity",
        "weight"
      ],
      "remaining_candidate_features": [
        "histological type of breast cancer",
        "type of surgical treatment",
        "lymph node status",
        "tumor size",
        "estrogen receptor status",
        "progesterone receptor status",
        "HER2/neu status",
        "left ventricular ejection fraction (LVEF)",
        "absolute neutrophil count (ANC)",
        "platelet count",
        "hemoglobin level",
        "bilirubin level",
        "AST level",
        "prior radiation therapy",
        "prior systemic anticancer therapy",
        "presence of motor or sensory neurotoxicity",
        "cardiac history",
        "presence of other serious illnesses or medical conditions",
        "urine protein:creatinine ratio",
        "history of other neoplasms",
        "concurrent hormonal therapy",
        "concurrent corticosteroid treatment",
        "concurrent experimental drug treatment",
        "hypersensitivity to study drugs",
        "surgical history",
        "mental condition or psychiatric disorder",
        "compliance likelihood"
      ]
    },
    "processed-gen-response": "Age, histological type of breast cancer, type of surgical treatment, lymph node status, tumor size, estrogen receptor status, progesterone receptor status, HER2/neu status, ECOG performance status, left ventricular ejection fraction (LVEF), absolute neutrophil count (ANC), platelet count, hemoglobin level, bilirubin level, AST level, prior radiation therapy, prior systemic anticancer therapy, presence of motor or sensory neurotoxicity, cardiac history, presence of other serious illnesses or medical conditions, urine protein:creatinine ratio, history of other neoplasms, concurrent hormonal therapy, concurrent corticosteroid treatment, concurrent experimental drug treatment, hypersensitivity to study drugs, surgical history, mental condition or psychiatric disorder, compliance likelihood."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Race/Ethnicity, Customized, Region of Enrollment, Estrogen Receptor (ER) Status, Progesterone Receptor (PR) Status, HER2/neu Status, ECOG Performance Status, Left Ventricular Ejection Fraction (LVEF), Absolute Neutrophil Count (ANC), Platelet Count, Hemoglobin Level, Bilirubin Level, AST Level, Tumor Size, Lymph Node Involvement,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Eastern Cooperative Oncology Group (ECOG) performance status score",
          "ECOG Performance Status"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Race/Ethnicity",
        "weight"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Region of Enrollment",
        "Estrogen Receptor (ER) Status",
        "Progesterone Receptor (PR) Status",
        "HER2/neu Status",
        "Left Ventricular Ejection Fraction (LVEF)",
        "Absolute Neutrophil Count (ANC)",
        "Platelet Count",
        "Hemoglobin Level",
        "Bilirubin Level",
        "AST Level",
        "Tumor Size",
        "Lymph Node Involvement"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Race/Ethnicity, Region of Enrollment, Estrogen Receptor (ER) Status, Progesterone Receptor (PR) Status, HER2/neu Status, ECOG Performance Status, Left Ventricular Ejection Fraction (LVEF), Absolute Neutrophil Count (ANC), Platelet Count, Hemoglobin Level, Bilirubin Level, AST Level, Tumor Size, Lymph Node Involvement"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Race/Ethnicity, Customized, Region of Enrollment, Body Mass Index, Systolic Blood Pressure, Diastolic Blood Pressure, Eastern Cooperative Oncology Group (ECOG) performance status score, Left Ventricular Ejection Fraction (LVEF), Absolute Neutrophil Count (ANC), Platelets, Hemoglobin, Bilirubin, AST levels, Human Epidermal growth factor Receptor 2 (HER2/neu) status, Estrogen Receptor (ER) status, Progesterone Receptor (PR) status.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Race/Ethnicity",
          "Race/Ethnicity"
        ],
        [
          "Eastern Cooperative Oncology Group (ECOG) performance status score",
          "Eastern Cooperative Oncology Group (ECOG) performance status score"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "weight"
      ],
      "remaining_candidate_features": [
        "Region of Enrollment",
        "Body Mass Index",
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure",
        "Left Ventricular Ejection Fraction (LVEF)",
        "Absolute Neutrophil Count (ANC)",
        "Platelets",
        "Hemoglobin",
        "Bilirubin",
        "AST levels",
        "Human Epidermal growth factor Receptor 2 (HER2/neu) status",
        "Estrogen Receptor (ER) status",
        "Progesterone Receptor (PR) status"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Race/Ethnicity, Region of Enrollment, Body Mass Index, Systolic Blood Pressure, Diastolic Blood Pressure, Eastern Cooperative Oncology Group (ECOG) performance status score, Left Ventricular Ejection Fraction (LVEF), Absolute Neutrophil Count (ANC), Platelets, Hemoglobin, Bilirubin, AST levels, Human Epidermal growth factor Receptor 2 (HER2/neu) status, Estrogen Receptor (ER) status, Progesterone Receptor (PR) status."
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, race, ethnicity, ECOG performance status, HER2/neu status, estrogen receptor status, progesterone receptor status, tumor size, histologic and/or nuclear grade, lymph node status, prior breast cancer treatment, prior radiation therapy, prior chemotherapy, prior hormonal therapy, prior surgery, left ventricular ejection fraction (LVEF), absolute neutrophil count (ANC), platelet count, hemoglobin, bilirubin level, AST level, creatinine level, urine protein:creatinine ratio.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "HER2/neu status"
        ],
        [
          "Race/Ethnicity",
          "race"
        ],
        [
          "Eastern Cooperative Oncology Group (ECOG) performance status score",
          "ECOG performance status"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "weight"
      ],
      "remaining_candidate_features": [
        "ethnicity",
        "estrogen receptor status",
        "progesterone receptor status",
        "tumor size",
        "histologic and/or nuclear grade",
        "lymph node status",
        "prior breast cancer treatment",
        "prior radiation therapy",
        "prior chemotherapy",
        "prior hormonal therapy",
        "prior surgery",
        "left ventricular ejection fraction (LVEF)",
        "absolute neutrophil count (ANC)",
        "platelet count",
        "hemoglobin",
        "bilirubin level",
        "AST level",
        "creatinine level",
        "urine protein:creatinine ratio"
      ]
    },
    "processed-gen-response": "Age, race, ethnicity, ECOG performance status, HER2/neu status, estrogen receptor status, progesterone receptor status, tumor size, histologic and/or nuclear grade, lymph node status, prior breast cancer treatment, prior radiation therapy, prior chemotherapy, prior hormonal therapy, prior surgery, left ventricular ejection fraction (LVEF), absolute neutrophil count (ANC), platelet count, hemoglobin, bilirubin level, AST level, creatinine level, urine protein:creatinine ratio."
  }
}